DSpace at RU >

Browsing by Author Poortmans, P.

Full Text	Issue Date	Title	Author(s)
	2011	The essential role of radiotherapy in the treatment of merkel cell carcinoma: a study from the rare cancer network	Ghadjar, P.; Kaanders, J.H.A.M.; Poortmans, P.; Zaucha, R.; Krengli, M., et al
	2009	Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.	Heutte, N.; Flechtner, H.H.; Mounier, N.; Mellink, W.A.M.; Meerwaldt, J.H., et al
	2008	The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines.	Girinsky, T.; Specht, L.; Ghalibafian, M.; Edeline, V.; Bonniaud, G., et al
	2007	Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882.	Antonini, N.; Jones, H.; Horiot, J.C.; Poortmans, P.; Struikmans, H., et al
	2007	Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.	Ferme, C.; Eghbali, H.; Meerwaldt, J.H.; Rieux, C.; Bosq, J., et al
	2006	Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines.	Girinsky, T.; Maazen, R.W.M. van der; Specht, L.; Aleman, B.; Poortmans, P., et al
	2005	Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884).	Aleman, B.; Girinsky, T.; Maazen, R.W.M. van der; Strijk, S.P.; Meijnders, P., et al
	2004	The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial.	Poortmans, P.; Bartelink, H.; Horiot, J.C.; Struikmans, H.; Bogaert, W. van den, et al